Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC10914 in gBRCA1/2-mutated Metastatic Breast Cancer
CTR20200060Phase 2Active
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SC10914 in breast cancer, sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Started Jul 2020; status: active.
02
Drugs
SC10914
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20200060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200060.